Mauro Vieira de Almeida

Mauro Vieira de Almeida

Auto-generated profile, based on publicly available information

Mauro Vieira de Almeida

Department of Chemistry, Federal University of Juiz de Fora, Campus Martelos, Juiz de Fora, MG, 36036-900, Brazil.

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JCJoana Darc S. Chaves
Joana Darc S. Chaves
LTLuiza Guimarães Tunes
Luiza Guimarães Tunes
Chris Hebert J FrancoChris Hebert J Franco
Chris Hebert J Franco
TFThiago Martins Francisco
Thiago Martins Francisco
CCCharlane Cimini Corrêa
Charlane Cimini Corrêa
MAMauro V. de Almeida
Mauro V. de Almeida

22 December 2015 in Virology Journal
Verified
Journal Article
Open access
PDF file
PZPaula Rodrigues Zanello
Paula Rodrigues Zanello
AKAndrea Cristine Koishi
Andrea Cristine Koishi
celso de oliveira Rezende Júniorcelso de oliveira Rezende Júnior
celso de oliveira Rezende Júnior
LOLarissa Albuquerque Oliveira
Larissa Albuquerque Oliveira
APAdriane Antonia Pereira
Adriane Antonia Pereira
JBJuliano Bordignon
Juliano Bordignon
Dengue is the most prevalent arboviral disease in tropical and sub-tropical areas of the world. The incidence of infection is estimated to be 390 million cases and 25,000 deaths per year. Despite these numbers, neither a specific treatment nor a preventive vaccine is available to protect people living in areas of high risk. With the aim of seeking a treatment that can mitigate dengue infection, we demonstrated that the quinic acid derivatives known as compound 2 and compound 10 were effective against all four dengue virus serotypes and safe for use in a human hepatoma cell line (Huh7.5). Both compounds were non-virucidal to dengue virus particles and did not interfere with early steps of the dengue virus life cycle, including binding and internalization. Experiments using a replicon system demonstrated that compounds 2 and 10 impaired dengue virus replication in Huh7.5 cells. Additionally, the anti-dengue virus effects of the quinic acid derivatives were preserved in human peripheral blood mononuclear cells. Taken together, these data suggest that quinic acid derivatives represent a novel chemical class of active compounds that could be used to combat dengue virus infection.

1 October 2007 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
MAMauro V. de Almeida
Mauro V. de Almeida
MSMaurício F. Saraiva
Maurício F. Saraiva
MSMarcus V.N. de Souza
Marcus V.N. de Souza
CCCristiane F. da Costa
Cristiane F. da Costa
FVFelipe R.C. Vicente
Felipe R.C. Vicente
MLMaria C.S. Lourenço
Maria C.S. Lourenço

24 August 2017 in BioMetals
Verified
Journal Article
Closed access
PDF file
AAAngelina Maria De Almeida
Angelina Maria De Almeida
BOBruno Assis De Oliveira
Bruno Assis De Oliveira
PCPedro Pôssa De Castro
Pedro Pôssa De Castro
CMCamille Carvalho De Mendonça
Camille Carvalho De Mendonça
RFRicardo Andrade Furtado
Ricardo Andrade Furtado
MAMauro Vieira De Almeida
Mauro Vieira De Almeida

1 May 2003 in Journal of Molecular Catalysis A: Chemical
Verified
Journal Article
Closed access
WAWendel A. Alves
Wendel A. Alves
SASaulo Afonso de Almeida-Filho
Saulo Afonso de Almeida-Filho
MAMauro Vieira de Almeida
Mauro Vieira de Almeida
APArmando Paduan-Filho
Armando Paduan-Filho
CBCarlos Castilla Becerra
Carlos Castilla Becerra
Ana Maria Da Costa FerreiraAna Maria Da Costa Ferreira
Ana Maria Da Costa Ferreira

1 January 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
DPDrielly Aparecida Paixão
Drielly Aparecida Paixão
CLCarla Duque Lopes
Carla Duque Lopes
ZCZumira A. Carneiro
Zumira A. Carneiro
LSLuana M. Sousa
Luana M. Sousa
LOLeticia P. de Oliveira
Leticia P. de Oliveira
WGWendell Guerra
Wendell Guerra
In order to improve the previously observed antichagasic activity of Cu(II) complexes containing 2-chlorobenzhydrazide (2-CH), we report herein the synthesis and anti-Trypanosoma cruzi activity of novel copper complexes containing 2-methoxybenzhydrazide (2-MH), 4-methoxybenzhydrazide (4-MH) and three α-diimine ligands, namely, 1,10-phenanthroline (phen), 2,2-bipyridine (bipy) and 4-4'-dimethoxy-2-2'-bipyridine (dmb). Two of these complexes showed higher in vitro anti-Trypanosoma cruzi activity when compared to benznidazole, the main drug used in Chagas disease treatment. One of them, the copper complex with 4-MH and dmb, [Cu(4-MH)(dmb)(ClO4)2], exhibited a higher selectivity index than that recommended for preclinical studies. Considering this observation, complex [Cu(4-MH)(dmb)(ClO4)2] was selected for preliminary in vivo assays, which verified that this compound was able to reduce parasitemia by 64% at the peak of infection. Further investigations were performed on all compounds. The Cu(II) complexes bind to ct-DNA with Kb values in the range of 103-104 M-1, with [Cu(4-MH)(dmb)(ClO4)2] showing the highest Kb value (1.45 × 104 M-1). Molecular docking simulations predicted that [Cu(4-MH)(dmb)(ClO4)2] binds in the minor groove of the double helix of ct-DNA and forms one hydrogen bond.